Browsing by Subject "4-component serogroup B meningococcal vaccine"
Now showing items 1-1 of 1
-
(Elsevier Ltd, 2019)Background: Data on duration of protection against invasive meningococcal disease post-vaccination with the recombinant, 4-component, meningococcal serogroup B vaccine (4CMenB) are limited. We evaluated bactericidal activity ...